The alternative protein market is set to be worth $290 billion by 2035 and Kernel™ is turning that trend into product demand.

Growth plans include strategic partnerships with food producers, augmented by Kernel™ own facilities. These new plants are enabled by the strategic capital from Union Group Ventures, the investment conglomerate which has become a substantial stakeholder in the business.

The company hinted at a potential public listing in 2022, supported by Union Group Ventures, in order to accelerate further Kernel’s ambitious plans, which includes a production capacity in excess of 50,000 tons per year in five years, in addition to a dozen new patents filed during 2022 and breaking ground in Kernel 1 - the first of several facilities to be built.